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Abstract
Current data suggest an important role of brain metabolic disturbances in the pathogenesis of depression and obesity, diseases that
frequently co-occur. Our aim was to determine whether there are changes in markers characterizing glucose metabolism in
prenatal stress (PS; animal model of depression), in rats fed a high-fat diet (HFD), and especially in the model of depression
and obesity co-occurrence. The changes in glucose-6-phosphate, glycogen, glucose transporters (GLUT1, GLUT4), glucagon-
like peptide-1 receptor (GLP-1R), and mitochondrial complexes levels in the frontal cortex and/or hippocampus were observed.
In the case of the coexistence of depression and obesity, the most important changes were (1) the decrease in the membrane form
of GLUT4, which may suggest weaker insulin action in the frontal cortex, and (2) the diminished GLP-1R, which could cause
neurodegenerative changes in the hippocampus. However, presented results suggested that HFD weakened the PS effect of
uncoupling oxidative phosphorylation in the frontal cortex.
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Abbreviations
BSA Bovine serum albumin
FCx Frontal cortex
G-6-P Glucose-6-phosphate
G6PD Glucose-6-phosphate dehydrogenase
GLP-1 Glucagon-like peptide-1
GLP-1R Glucagon-like peptide-1 receptor
GLP-2 Glucagon-like peptide-2
GLP-2R Glucagon-like peptide-2 receptor
GLUT Glucose transporter
HFD High-fat diet
Hp Hippocampus
HPA Hypothalamic–pituitary–adrenal axis
OCR Oxygen consumption rate
OXPHOS Oxidative phosphorylation
PDH Pyruvate dehydrogenase
PFK-1 L Phosphofructokinase
PS-NR Prenatal stress-nonreactive
PS-R Prenatal stress-reactive
SDS Sodium dodecyl sulfate
UCP4 Uncoupling protein 4
Introduction
Epidemiological studies indicate a frequent comorbidity of
major depression and obesity. These diseases affect an in-
creasing number of people and have become a serious medical
and social burden (Renn et al. 2011; Lopresti and Drummond
2013). People with diabetes type 1 or type 2 or obesity suffer
from depression twice as often as people without this disease
(de Groot et al. 2001) and, on the other hand, about doubled
increased risk of obesity was found in patients with bipolar
disorders than in control people (Goldstein et al. 2011).
Moreover, obese people with bipolar disorder have longer
and more severe depressive episodes and the therapeutic ef-
fects of some antidepressant drugs are slower and weaker
(Woo et al. 2016). The reasons for this mutual relationship
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between obesity and depression are unknown, but following
conditions are considered as possible mediators: unhealthy
dietary patterns, low physical activity, sleep disorders, meta-
bolic disorders, mitochondrial disturbances, increased inflam-
mation, oxidative stress, neuroprogression, early-life trauma,
and hypothalamus–pituitary–adrenal (HPA) axis disturbances
(Lopresti and Drummond 2013). The results of many studies
show that chronic stress associated with mild activation of
HPA axis may be an important factor in the pathogenesis of
depression and that prolonged stress combined with an in-
creased consumption of a high-fat diet (HFD) are key factors
in the development of obesity (Ayanian et al. 2009). In con-
trast to the stress occurring in adults, the effects of which are
usually short term and disappear after the end of the stress
factor action, stress in the prenatal or early postnatal period
often permanently changes the HPA axis activity and in-
creases the risk of depression, metabolic, and cardiovascular
disorders (Bose et al. 2009; Murgatroyd et al. 2009;
Szymańska et al. 2009; Reynolds 2010).
Accumulating evidence suggests that metabolic distur-
bances in brain structures involved in mood regulation
may be involved in the pathogenesis of depression. In
addition, obesity, often resulting from consumption of
high-fat diet, causes or intensifies metabolic changes not
only in the periphery but also in the brain (Hryhorczuk
et al. 2013; Lopresti and Drummond 2013). Since glucose
is practically the only energy source for brain cells, the
disturbances in its metabolism may be key factors in the
pathogenesis of both obesity and depression. Although the
glucose metabolism in the brain is not yet fully under-
stood, most of this carbohydrate in the human brain is
oxidized to produce large amounts of ATP necessary to
maintain proper brain cells function, including neuronal
transmission. Glycolysis occurs mainly in astrocytes and
lead principally to the formation of lactate. Some amount
of lactate may be taken up by neurons, converted to py-
ruvate and then metabolized via the Krebs cycle through
oxidative phosphorylation (Kasischke et al. 2004; Goyal
et al. 2014). The oxidative phosphorylation process occurs
mainly in neurons, cells which need the greatest amount
of energy stored in ATP. In addition to glycolysis, in the
brain, glucose is metabolized also in the pentose cycle, a
major source of NADPH needed for reactive oxygen spe-
cies removal. Brain glycogen is stored mainly in astrocytes
and when the energy demand increases, it is metabolized
to lactate and may be transported to neurons. However,
the level of glycogen in the brain is low compared to
peripheral tissues and its level usually correlates with neu-
ral activity. With regard to the regulation of glucose me-
tabolism in the brain, particular interest is focused on the
role of endocrine factors, such as glucocorticoids, insulin,
and incretin hormones (Gerozissis 2008; Duarte and
Moreira 2012; Ghasemi et al. 2013).
The adverse effect of glucocorticoids on peripheral metab-
olism, such as an increase in blood glucose level and induction
of insulin resistance have been identified, but the metabolic
action of this hormone in brain structures is still poorly under-
stood. However, it is known that chronic unpredictable mild
stress evokes glucose intolerance and impairs hypothalamic
insulin signaling in rats (Pan et al. 2013). Long-term admin-
istration of corticosterone or removing the source of its pro-
duction (adrenalectomy) changes the activity of enzymes that
metabolize glucose and glycogen in certain structures of the
cerebral cortex and the hippocampus (Plaschke et al. 1996;
Hoyer and Lannert 2008). Our previous research also demon-
strated changes in the concentration and metabolism of glu-
cose in the frontal cortex and hippocampus of prenatally
stressed rats, one of the animal models of depression (Detka
et al. 2014, 2015). However, these changes, while only slight
under basic conditions, were much more significant under the
influence of aversive factors, such as glucose loading or acute
stress, acting on these animals as adults, which is consistent
with the hypothesis that stress in this period of life intensifies
the effects of unfavorable factors acting later in life.
The action of brain insulin and the incretin hormone
glucagon-like peptide 1 (GLP-1) on the regulation of feeding
behavior and glucose homeostasis is connected and so far has
mainly been studied in the hypothalamus; however, it is
known that these hormones enhance neuronal survival in other
brain structures, mainly the hippocampus, and improve cog-
nitive processes (Detka et al. 2013). Therefore, as observed in
both depression and obesity, disturbances in synaptic plastic-
ity, and cognitive dysfunction may result from changes in the
levels or action of both insulin and GLP-1; however, it is
unclear whether this effect is due to their direct action or re-
lated to their effects on metabolic processes in these regions of
the brain. Normal metabolism, whose main substrate in the
brain is glucose, determines the maintenance of the membrane
potential and the proper function of neurons, so metabolic
changes can be crucial not only in mental illness but also in
the cognitive disturbances observed in other diseases.
Because current studies indicate the occurrence of metabol-
ic disturbances in the brain in depression, type II diabetes, and
obesity, the aim of the present study was to determine whether
there are changes in selected markers characterizing glucose
metabolism and whether they are accompanied by distur-
bances in insulin, GLP-1, and their receptors levels in an an-
imal model of depression and in rats fed with a high-fat diet.
Because the high-fat diet influences the effects caused by
stress in a different way, the aim of the present study was also
to assess the impact of HFD on the prenatal stress effect.
Additionally, since prenatal stress was used in the present
study as an animal model of depression and not all animals
evoked depression-like behavioral changes, (which were ver-
ified by an increase in immobility time in the Porsolt test),
prenatally stressed rats were divided into prenatal stress-
Neurotox Res (2020) 37:406–424 407
reactive (PS-R) and prenatal stress-nonreactive (PS-NR)
groups. Despite the use of identical stressors, not all animals
show depression-like behavior; such a situation has also been
observed in other animal models of this disease (Kolasa et al.
2014). Selected metabolic markers were determined in the
hippocampus and frontal cortex, since changes are mainly
observed in those structures in depression and the adverse
effects of prenatal stress occur in these structures as well.
Materials and Methods
Animal Treatment
Animals
Sprague-Dawley rats (Charles River Laboratories, Hamburg,
Germany) with an initial weight of 200–250 g were main-
tained at a room temperature of 22 ± 2 °C on a 12-h light/
dark cycle (lights on at 6:00 am) with food and water available
ad libitum. All experiments were performed according to the
National Institutes of Health Guide for the Care and Use of
Laboratory Animals and were approved by the Local Ethics
Committee in Krakow, Poland (permission no. 1144/2015).
Prenatal Stress Procedure
One week after arrival, vaginal smears from females were
collected daily to determine the phase of the estrous cycle.
During proestrus, female rats were placed with males for 12
h. Next, vaginal smears were tested for the presence of sperm.
Pregnant females were then randomly assigned to the control
and stress groups. Prenatal stress was applied as previously
described (Morley-Fletcher et al. 2003; Glombik et al. 2017).
Briefly, pregnant female rats were subjected to three daily
sessions of immobility stress (starting at 09:00 am, 12:00
pm, and 05:00 pm). During these times, animals were placed
in plastic cylinders (7/19 cm) and exposed to a bright light (2 ×
150 W bulbs) for 45 min. The stress sessions were performed
from day 14 of pregnancy until delivery. Control pregnant
females were left undisturbed in their home cages. Twenty-
one days after birth, male offspring from litters containing 10–
14 pups with a comparable number of males and females were
separated for further experiments (1–2 rats from the same litter
were used in the study). The rats were housed in groups of five
per cage under standard conditions until 3 months of age.
Forced Swim Test in Rats
The 3-month-old animals were individually subjected to two
trials in which they were forced to swim in a cylinder filled with
water (23 °C) up to a height of 35 cm. The first trial (pretest)
lasted 15min, and the second trial lasted 5min, during which the
total duration of immobility was measured. Then, the prenatally
stressed rats were divided into groups: prenatal stress-responsive
and prenatal stress-nonresponsive groups.
(a) Prenatal stress reactive (PS-R): rats in which the total
immobility time was significantly higher than the immo-
bility time of the control group. In these animals, the
immobility time was by > 1 SD higher than the mean
of the control rats.
(b) Prenatal stress nonreactive(PS-NR): rats in which no sig-
nificant differences in immobility time were present
compared to the immobility time of the control group.
Forced swim test was repeated after 16 weeks of diet.
Diet
Rats from the prenatally stressed groups and the control
group were transferred in groups of four animals to one
cage and then divided into two dietary groups: (i) a
group fed with standard laboratory chow (STD) contain-
ing 13.6% kcal from fat (61.5% kcal from carbohy-
drates; 24.9% kcal from protein) and (ii) a group fed
with a high-fat diet (HFD) containing 45% kcal from
unsaturated fat (lard) (35% kcal from carbohydrates;
20% kcal from protein). Both chows were purchased
in the laboratory chow producer “Wytwórnia Pasz
Morawski” Kcynia, Poland. The animals were fed a
standard or high-fat diet for 16 weeks, and during this
time, they were weighed every 7 days.
The timeline showing the experimental design is illustrated in
Fig. 1.
Biochemical Analysis
Two independent animal experiments were performed. All
biochemical experiments were carried out with single repeti-
tion of each individual sample, exactly the same conditions for
every sample, regardless of the type of animal treatment.
Tissue Collection
The animals were sacrificed under nonstressful conditions by
rapid decapitation (rats were not fasted before sacrifice). The
brains were rapidly removed, and the hippocampus and frontal
cortex were dissected on ice-cold glass plates. Tissues were fro-
zen on dry ice and stored at − 80 °C till the biochemical assays.
Key metabolites and enzymes of glycolysis, pentose phos-
phate pathway, Krebs cycle, and oxidative phosphorylation
determined in present study are shown on Scheme 1.
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Glycogen Assay
Glycogen concentration in the frontal cortex and hippocampus
was measured with an enzymatic method using a fluorimetric
assay kit (#K646-100; BioVision, USA). Samples were homog-
enized in 5 volumes of redistilledwater, boiled for 5min at 96 °C
to inactivate the enzymes and centrifuged at 20,000×g for 20
min. Forty microliters of each supernatant was transferred to a
96-well plate along with blanks and standards (0.2, 0.4, 0.6, 0.8,
and 1.0 μg per well). In the selected assay, glycogen is hydro-
lyzed to glucose (by glucoamylase), which is subsequently oxi-
dized and reacts with an OxiRed probe to produce a fluorophore.
Fluorescence intensity was measured at excitation and emission
wavelengths of 535 and 590 nm, respectively, with a fluorometer
(Tecan Infinite 200 Pro, Switzerland). The concentration of gly-
cogen was calculated by subtracting the background fluores-
cence (amount of glucose in unhydrolyzed samples) from the
fluorescence intensity of the samples after hydrolysis.
Glycogen levels were then calculated from the standard curve
and displayed as μg/mg of protein.
Glucose-6-Phosphate Assay
The levels of glucose-6-phosphate (G-6-P) in the examined
brain structures were determined with enzymatic methods
using colorimetric assay kits (#K657-100, BioVision, USA).
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Scheme 1 The simplified diagram of cellular glucose metabolism, illustrating key metabolites and enzymes of glycolysis, pentose phosphate pathway,
Krebs cycle, and oxidative phosphorylation, which were measured in the experiment
Fig. 1 The timeline showing experimental design. Control (Ctrl) and
prenatally stressed (PS) male rats were subjected to forced swim test
(FST) at 3 months of age. After FST, PS rats were divided into prenatal
stress-reactive (PS-R) and prenatal stress-nonreactive (PS-NR) on the
basis of total immobility time in the test. Subsequently, the animals from
both stressed groups and control rats consumed standard (STD) or high-
fat diet (HFD) for 16 weeks. After this time period, FST was conducted
once again, animals were sacrificed, and brain structures were isolated for
biochemical assays
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Brain tissues were homogenized in PBS, centrifuged at
20,000×g for 20 min at 4 °C, and deproteinized using a
perchloric acid/KOH protocol (#K808-200; BioVision,
USA). Fifty-microliter aliquots of samples were transferred
to 96-well plates, mixed with 50 μl of Reaction Mix and
incubated at room temperature for 30 min. The absorbance
was measured at λ = 450 nm (Tecan Infinite 200 Pro spectro-
photometer, Switzerland). The concentration of G-6-P was
calculated from the standard curve and displayed as nmol/
mg of protein.
Determination of L-Lactate
To measure the concentration of L-lactate in selected brain struc-
tures, tissues were homogenized in PBS, centrifuged (20,000×g;
20 min.; 4 °C) and deproteinized using a perchloric acid/KOH
protocol (#K808-200; BioVision, USA). The level of lactate in
the samples was measured with a colorimetric assay kit (#K607-
100, BioVision, USA). Seven-microliter aliquots of the samples
were transferred to a 96-well plate and mixed with 50 μl of
Reaction Mix. After a 30-min incubation, the absorbance was
measured at λ = 570 nm. The concentration of lactate in each
sample was calculated from the standard curve and finally
displayed as nmol/mg of protein.
Enzyme-Linked Immunosorbent Assay (ELISA)
The concentrations of phosphofructokinase, glucose transporter
(GLUT1), GLP-1, GLP-1 receptor (GLP-1R), GLP-2 receptor
(GLP-2R), insulin, and active (phosphorylated at tyrosine
1162/1163) and total insulin receptor (phospho-IR and IR) in
selected brain structures were determined by using an ELISA
method with commercially available assay kits (GLUT1:
SEB185Ra, USCN Life Science Inc.; Phosphofructokinase:
SED406Ra, USCN Life Science Inc.; GLP-1: EGLP-35K,
Merck Millipore; GLP-1R: MBS2031967, MyBioSource;
GLP-2R: MBS 9321753, MyBioSource; insulin: RI-13K,
Merck Millipore; phospho-IR: 17-484, Merck Millipore; IR:
17-483, Merck Millipore p-IRS: 17-459 Merck Millipore).
Each individual sample was transferred to a precoated 96-well
ELISA plate along with the appropriate standards, blanks, and
positive controls. The concentrations of selected markers were
calculated from the standard curve and subsequently divided by
the protein content in a given sample.
Determination of Pyruvate Dehydrogenase Activity
Pyruvate dehydrogenase activity was measured with a color-
imetric assay kit (#K679-100, BioVision, USA). Brain struc-
tures were homogenized in 4 volumes of assay buffer, centri-
fuged at 10,000×g for 5 min at 4 °C. Ten microliters of each
supernatant was transferred in to a 96-well assay plate along
with the appropriate standards and subsequently mixed with
50 μl of Reaction Mix. The plate was then placed in a spec-
trophotometer (Tecan Infinite M200 Pro, Switzerland). The
absorbance was measured at 37 ° C every 10 min for a total
time of 1 h, λ = 450 nm. Activity of pyruvate dehydrogenase
was then calculated and finally displayed as nmol/min/mg of
protein.
Determination of Glucose-6-Phosphate Dehydrogenase
Activity
The activity of glucose-6-phosphate dehydrogenase in the
frontal cortex and hippocampus was measured using a color-
imetric assay kit (MAK015, Sigma-Aldrich, USA). Brain tis-
sues were homogenized in four volumes of PBS and centri-
fuged at 15,000×g (10 min, 4 °C). Forty-microliter aliquots of
the supernatants were transferred to a 96-well plate and mixed
with 50 μl of Master Reaction Mix. The absorbance was mea-
sured two times at a wavelength of λ = 450 nm: first, imme-
diately after substrate addition and the second time, after
20 min in order to determine reaction kinetics. The activity
of the enzyme was calculated from the standard curve and
finally displayed as mU/mg of protein.
Isolation of Mitochondria-Enriched Membrane and Cytosolic
Fractions
To determine the activity and the amount of selected mitochon-
drial enzymes, as well as measure the translocation of GLUT4 to
the cell membrane, mitochondria-enriched membrane fraction
was isolated from the frontal cortex and hippocampus according
to the procedure described by Wernicke et al. (2010). Briefly,
brain tissues, kept on ice, were homogenized in a motor-driven
Teflon-glass homogenizer in four volumes of homogenization
buffer containing 5 mol/l HEPES/NaOH, pH 7.4, 320 mmol/l
sucrose, and 1 mmol/ l Na+/EDTA with the addition of 0.5%
protease inhibitor cocktail (Sigma-Aldrich, USA). After centrifu-
gation at 1300×g (4 min, 4 °C), supernatants were collected.
Additionally, to increase the yield, the pellet was washed twice
with homogenization buffer and centrifuged at 1500×g (4 min, 4
°C). To collect the mitochondria, supernatants were combined
and centrifuged at 17,000×g for 12 min at 4 °C. The obtained
pellets containing mitochondria and supernatants (containing the
cytosolic fraction) were rapidly frozen and stored at − 80 °C.
Determination of GLUT4 Concentration in Membrane
and Cytosolic Fractions
Level of GLUT4 in the frontal cortex and hippocampus was
measured by using the ELISA method using a specific assay
kit (E2023r, Wuhan EIAab® Science Co., Ltd, China). The
membrane fraction was initially suspended in PBS, sonicated
in order to release membrane-bound proteins, and centrifuged
at 12,000×g for 12 min at 4 °C. After centrifugation,
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supernatants were transferred to a precoated 96-well plate
along with blanks and standards. The cytosolic fraction was
directly aliquoted into an ELISA plate. The final concentra-
tions of GLUT4 in both cellular fractions were displayed as
ng/mg of protein.
Immunoblotting To Detect Expression of Phospho-Akt/Akt (in
Tissue Homogenates) and Respiratory Chain Complexes
(CI-CV), Neuronal Uncoupling Protein 4 (UCP4) (in
Mitochondria-Enriched Membrane Fraction)
The brain structures were lysed in 2% SDS (BioShop,
Canada), while the isolated mitochondria-enriched membrane
fraction was lysed in PBS (containing 1% Triton X-100, 0.1%
SDS, phosphate, and protease inhibitors (Thermo Fisher
Scientific, USA)). Then, samples were shaken for 10 min
and centrifuged for 10 min, at 12,000×g. Samples containing
equal amounts of total protein weremixed with the gel loading
buffer (Bio-Rad, Hercules, USA) in a 4:1 ratio (v/v) and incu-
bated at 37 °C for 5 min (mitochondria-enriched fraction
samples) or at 95 °C for 8 min (homogenate samples). Next,
proteins were separated by SDS-PAGE (4–20% gel, Bio-Rad,
USA) under constant voltage (150 V). After electrophoresis,
proteins were transferred to PVDF membranes. The blots
were blocked in 5% nonfat dried milk in PBS with 0.05%
Tween 20 (Sigma-Aldrich, USA) or BSA for 1 h at room
temperature (RT) and incubated overnight at 4 °C with
phospho-Akt (Ser473) (1:2000, #4060, Cell Signaling,
USA), OXPHOS Rodent WB Antibody Cocktail at a
6.0-μg/ml working concentration (ab110413, Abcam, UK)
or UCP4 Polyclonal Antibody (1.0 μg/ml, PA5-69265,
Thermo Fisher Scientific, USA) that had been diluted in a
SignalBoost Immunoreaction Enhancer Kit (Merck
Millipore, USA). The day after, membranes were rinsed 3 ×
10min in PBST (PBSwith 0.05% Tween 20) and incubated at
RT with horse anti-mouse/goat anti-rabbit IgG HRP
peroxidase-conjugated secondary antibody (PI-2000, PI-
1000; respectively, Vector Laboratories, UK) for 1 h. After
washing for 4 × 10 min in TBST (Tris-buffered saline with
0.05% Tween 20), the bands were developed using BM
Chemiluminescence Western Blotting Substrate (POD)
(Roche, Germany). The protein pattern images were obtained
using a Fujifilm LAS-1000 System (Fuji Film, Japan). The
relative levels of immunoreactivity were densitometrically
quantified using the Fujifilm Multi Gauge software (Fuji
Film, Japan). The blots were stripped using stripping buffer
containing 100 ml of Tris-HCl (pH = 6.7), 2% SDS, and
700 μl of 2-mercaptoethanol (all from Sigma-Aldrich,
USA); washed three times for 10 min each in TBST; blocked;
and reprobed with an antibody against β-actin (A5441,
Sigma-Aldrich, USA) as an internal loading control at a dilu-
tion of 1:15,000 in a SignalBoost Immunoreaction Enhancer
Kit (Merck Millipore, USA). Concerning the Akt kinase, the
stripping procedure was used to detect the total form of Akt
(1:3000, #9272, Cell Signaling, USA). β-Actin was deter-
mined at the same time as the phosphorylated form of Akt
(after transfer, the membranes were cut to allow simultaneous
incubation with two antibodies: phospho-Akt and β-actin).
ATP Assay
The intracellular ATP content was measured using an
ATPlite™ Luminescence ATP Detection Assay System
(Perkin Elmer, USA). The results were calculated as nmol
ATP, adjusted for protein content, and reported as nmol
ATP/g of protein (Sliwa et al. 2012).
Mitochondrial Respiratory Function
The respiration of brain mitochondria was measured at 37 °C
by high-resolution respirometry with an Oxygraph-2k
(Oroboros Instruments, Austria). Rats were sacrificed, and
the frontal cortex was removed and briefly placed in tubes
containing ice-cold homogenization buffer (0.25 M sucrose,
50 mM KCl, 5 mM EDTA, 1 mM sodium pyrophosphate,
5 mM MgCl2 (pH 7.4), Sigma-Aldrich, USA) with freshly
added protease inhibitor cocktail (Thermo Fisher Scientific,
USA). Tissue was homogenized 10 times with a Teflon-
glass homogenizer on ice, and the homogenates were centri-
fuged at 1300 rpm for 10 min (4 °C). The supernatants were
collected (SN1), and the pellet were resuspended in 4 volumes
of homogenization buffer. Samples were centrifuged as de-
scribed previously, and supernatant was collected (SN2).
SN1 and SN2 were mixed and centrifuged at 9000×g for 15
min. Then, the pellet was resuspended carefully in 5 volumes
of homogenization buffer. The protein level was measured
using the BCA method (Smith et al. 1985). We used 300 μg
of isolated mitochondria suspended in 2 ml of MiR05 respi-
ration buffer (in mmol/l, EGTA 0.5, MgCl2·6H2O 3, K-
lactobionate 60, taurine 20, KH2PO4 10, HEPES 20, sucrose
110, fatty acid-free BSA 1 g/L, pH 7.0 with KOH, Sigma-
Aldrich, USA) per Oxygraph-2k chamber for each experiment
(based on preliminary experiments). Mitochondrial respira-
tion was measured in the presence of substrates (glutamate
and malate). All respiration measurements were made follow-
ing this protocol: glutamate (10 mM) and malate (2 mM)
without ADP (leak state); respiration assessed by the addition
of 2.5 mM ADP (ADP-stimulated state, control of coupled
respiration by complex I) and, next, the addition of 10 mM
succinate (CI + CII OXPHOS state). Then, uncoupling control
through the titration of the protonophore carbonylcyanide-
4-(trifluoromethoxy)-phenylhydrazone (FCCP)-uncoupled
state, optimal for 0.25 μM) was measured (Pesta and
Gnaiger 2012; Sebastian et al. 2012). Finally, rotenone (1
μM) and antimycin A (2.5μM)were added to inhibit complex
I and complex II, respectively. Inhibition of respiration of
Neurotox Res (2020) 37:406–424 411
uncoupled mitochondria leads to evaluation of oxygen flux
due to oxidative side reactions (residual oxygen consumption,
ROX). Data from high-resolution respirometry were analyzed
using the DatLab 4 software (Oroboros, Austria) and are pre-
sented as O2 flux per mass, ROX-corrected.
Mitochondrial respiratory function was measured only in
the frontal cortex in four groups: control animals fed with
standard and high-fat diet and animals responding to prenatal
stress (increased immobility time in the Porsolt test) receiving
standard and high-fat diet.
Measurement of Protein Concentration
The protein concentration in tissue homogenates was mea-
sured with the bicinchoninic acid method (Smith et al. 1985)
using a Pierce™ BCA Protein Assay Kit (Thermo Fisher
Scientific, USA).
Statistical Analysis
All data are presented as the mean ± SEM. The results were
analyzed using the STATISTICA software. The subsequent
statistical analyses used factorial ANOVA of the PS/diet to
determine the effects of the examined factors. Next,
Duncan’s post hoc test was applied. A p value < 0.05 was
considered to indicate significance.
Results
Prenatal Stress Affected the Behavioral Parameters
Measured in the Forced Swim Test
ANOVA revealed a significant effect of PS on total
immobility time (F2,93 = 53.25, p < 0.0001) measured
in the forced swim test (Fig. 2A). Furthermore, post hoc
analysis showed that prenatally stress-reactive (PS-R)
rats were characterized by extended total immobility
time (p = 0.0001) in comparison to control animals,
whereas prenatal stress nonreactive rats (PS-NR)
displayed no significant differences in this parameter
when compared to control. After the 16-week consump-
tion of a high-fat diet, an effect of PS (F2,42 = 12.71, p
< 0.0001) and PS/HFD interaction (F2,42 = 6.13, p =
0.0046) on the immobility time was showed. The post
hoc test revealed that PS-R rats fed the standard diet
exhibited significantly higher levels of immobility be-
havior (p = 0.0040) than Ctrl/STD animals (Fig. 2B).
Additionally, Ctrl/HFD rats displayed lower levels of
immobility behavior (p = 0.0048) in the FST than
Ctrl/STD group.
SixteenWeeks of High-Fat Diet IncreasedWeight Gain
Factorial ANOVA showed the effects of PS (F2,83 = 9.28, p =
0.0002) and HFD (F1,83 = 32.09, p < 0.0001) on weight gain
after 16 weeks of feeding. Groups of animals fed with HFD
shown marked increase in body weight gain, when compared
to appropriate control groups, which consumed standard lab-
oratory chow (control/HFD vs. control/STD: p = 0.0004; PS-
R/HFD vs. PS-R/STD: p = 0.0020; PS-NR/HFD vs. PS-NR/
STD: p = 0.0226) (Fig. 2C).
PS Increased Glucose-6-Phosphate and Glycogen
Level in the Frontal Cortex and Hippocampus,
Whereas HFD Increased Glucose-6-Phosphate
in the Hippocampus
To assess metabolic changes in the examined models of de-
pression and obesity, first, a concentration of glucose-6-phos-
phate, the main intracellular substrate of carbohydrate metab-
olism, and the content of glycogen, a compound that is an
intracellular energy store, were determined.
We observed that PS (F2,41 = 13.95, p < 0.0001), HFD
(F1,41 = 10.43, p = 0.0024), and PS/HFD interaction (F2,41 =
3.79, p = 0.0308) affected the concentration of glucose-6-
phosphate in the hippocampus (Fig. 3B), whereas in the fron-
tal cortex, only PS (F2,42 = 9.10, p = 0.0006) showed such an
action (Fig. 3A). In the hippocampus, glucose-6-phosphate
concentration was increased in all experimental groups in
comparison to the control rats (control/HFD: p = 0.0069;
PS-R/STD: p = 0.0073; PS-R/HFD: p = 0.0154; PS-NR/
STD: p = 0.0152; PS-NR/HFD: p < 0.0001) and in PS-NR/
HFD vs. PS-NR/STD: p = 0.0052, while in the frontal cortex,
its level was enhanced in the PS-R animals fed with a HFD (p
= 0.0171) and in PS-NR rats fed with STD (p = 0.0279), HFD
(p = 0.0077) diet.
Factorial ANOVA showed that glycogen levels in both
brain structures were changed by prenatal stress (F2,41 =
3.56, p = 0.0375 Hp and F2,42 = 6.63, p = 0.0032 FCx), but
no effect of a HFD or the PS/HFD interaction was observed
(Fig. 3C, D). We showed an elevated glycogen level in the
hippocampus in PS-R rats fed with a STD (p = 0.0256) and in
PS-NR animals receiving a HFD (p = 0.0245) and in the
frontal cortex in PS-R rats fed a HFD (p = 0.0423) and in
PS-NR animals fed both a STD (p = 0.0017) and HFD (p =
0.0087).
Upregulation of GLUT1 and Downregulation
of the Active Form of GLUT4 in the Frontal Cortex
Since an increase in glucose-6-phosphate and glycogen levels
may be due to augmentation of glucose transport into the cell,
therefore, next, the protein expression of glucose transporters
GLUT1 and GLUT4 was assayed.
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ANOVA revealed a significant effect of PS (F2,40 = 4.32, p =
0.0199) on GLUT1 expression in the hippocampus and an effect
of PS (F2,42 = 3.44, p = 0.0415) and HFD (F1,42 = 5.18, p =
0.0280) on the level of this transporter in the frontal cortex (Fig.
4A, B). An increase in GLUT1 in the PS-NR/HFD group vs.
control/STD (p = 0.0037) and PS-NR/STD (p = 0.0233) rats in
the frontal cortex was shown by the post hoc test. Despite the
main effect of PS showed by analysis of variance, post hoc test
showed that in the hippocampus, therewas no change in the level
of this transporter in any of the studied groups.
The GLUT4 transporter was measured in the membrane
(active form) and cytosol fraction. In the frontal cortex
ANOVA displayed a significant effect of the PS/HFD interac-
tion (F2,39 = 3.78, p = 0.0316) onmembraneGLUT4. Post hoc
test showed a decreased level of this transporter in PS-R/HFD
rats in comparison to that in control/STD (p = 0.0253) and PS-
R/STD rats (p = 0.0182) (Fig. 4C). In the hippocampus, no
effect of prenatal stress, HFD, or the PS/HFD interaction on
GLUT4 in the membrane fraction was observed (Fig. 4D).
Despite the main effect of PS (F2,40 = 3.69, p = 0.034)
Fig. 2 The effect of prenatal
stress on immobility time (A) in
forced swim test. n = 32. The
effect of prenatal stress and 16-
week consumption of high-fat di-
et on immobility time (B) in
forced swim test. n = 8. The effect
of 16-week consumption of high-
fat diet on body weight gain of
animals from control and prenatal
stress-reactive (PS-R) and prena-
tal stress nonreactive (PS-NR)
group (C). n = 14-16. The results
are expressed as the means ±
SEM. (a) Statistically significant
effect of prenatal stress; (b) sta-
tistically significant effect of
HFD; *p < 0.05 vs. control group
(without prenatal stress, fed with
STD); #p < 0.05 vs. appropriate
STD group
Fig. 3 The effect of prenatal
stress and high-fat diet on
glucose-6-phosphate (G-6-P) (A,
B) and glycogen (C, D) contents
in the frontal cortex (A, C) and
hippocampus (B, D). The results
are expressed as the means ±
SEM. (a) Statistically significant
effect of prenatal stress; (b) sta-
tistically significant effect of
HFD; (a*b) statistically signifi-
cant effect of prenatal stress/HFD
interaction. *p < 0.05 vs. control
group (without prenatal stress, fed
with STD); #p < 0.05 vs. appro-
priate STD group. n = 6–8
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demonstrated by the analysis of variance in the hippocampus,
there were no differences in the content of GLUT4 in the
cytosol fraction in this structure (Fig. 4F). Moreover, it was
found that none of the factors had an effect on cytosolic
GLUT4 in the frontal cortex (Fig. 4E).
PS and HFD Affected Lactate, but Not
Phosphofructokinase Concentrations
The indicated increased level of glucose-6-phosphate may re-
sult from attenuation of glycolysis process, and therefore, ex-
pression of the key enzyme of this process and the main gly-
colysis product in the brain were determined.
It was found that none of the factors (PS, HFD, or PS/HFD
interaction) had an effect on phosphofructokinase expression
in the frontal cortex and hippocampus (Fig. 5A, B). Also none
of the factors (PS, HFD, or PS/HFD interaction) affected the
level of lactate, the main glycolytic product in the brain in the
frontal cortex (Fig. 5C).
In the hippocampus, we observed an effect of the PS/HFD
interaction (F2,42 = 3.48, p = 0.0401), but not PS and HFD, on
lactate concentration. The post hoc test showed a decrease in
this glycolytic marker in PS-NR/STD rats compared with
control/STD rats (p = 0.0076) and increase in PS-NR/HFD
rats vs. PS-NR/STD (p = 0.0259) (Fig. 5D).
Increased Glucose-6-Phosphate Dehydrogenase
Activity in the Frontal Cortex of PS-R Rats
In addition to the glycolysis process, glucose can be metabo-
lized also in the pentose cycle that is a major source of
NADPH used for reactive oxygen species removal.
Weakened activity of the pentose cycle enzymes could be
the cause of both the nerve cell damage by ROS and increased
level of glucose-6-phosphate; therefore, the activity of the key
enzyme of this process was determined.
PS (F2,42 = 7.38, p = 0.0018) but not the HFD or PS/
HFD interaction significantly affected the activity of
glucose-6-phosphate dehydrogenase in the frontal cortex
(Fig. 6A). Increased activity of this enzyme in the frontal
cortex in prenatal stress-responsive rats fed with the STD
in relation to the control/STD (p = 0.0013) group was
shown by further analysis. In the hippocampus, PS/HFD
interaction (F2,42 = 7.42, p = 0.0017) was indicated and
the activity of this enzyme was lower in the PS-NR rats
fed with the HFD compared to the control/STD (p =
0.0024) and PS-NR/STD groups (p = 0.0022). The
Fig. 4 The effect of prenatal
stress and high-fat diet on GLUT1
concentrations in the frontal cor-
tex (A) and hippocampus (B),
GLUT4 levels in the membrane
(C) and cytosol (E) fractions of
the frontal cortex, and GLUT4
levels in the membrane (D) and
cytosol (F) fractions of the hip-
pocampus. The results are
expressed as the means ± SEM.
(a) Statistically significant effect
of prenatal stress; (b) statistically
significant effect of HFD; (a*b)
statistically significant effect of
prenatal stress/HFD interaction.
*p < 0.05 vs. control group
(without prenatal stress, fed with
STD); #p < 0.05 vs. appropriate
STD group. n = 6–8
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activity of glucose-6-phosphate dehydrogenase in PS-R/
HFD was higher in comparison to control /HFD group
(p = 0.0253).
HFD Decreased Activity of Pyruvate Dehydrogenase
in the Hippocampus
To check the possibility that increased level of glucose-6-
phosphate resulted from Krebs cycle attenuation, activity of py-
ruvate dehydrogenase, the key enzyme responsible for placing
the products of glycolysis to the Krebs cycle, was determined.
ANOVA showed no effect of PS, HFD, and their interac-
tion on the activity of pyruvate dehydrogenase, one of the first
important enzymes in the Krebs cycle, in the frontal cortex
(Fig. 7A). In the hippocampus, HFD (F1,42 = 5.08, p = 0.0295)
affected the activity of this enzyme (Fig. 7B). Pyruvate dehy-
drogenase activity was decreased in the control/HFD group (p
= 0.0184) and in prenatal stress-responsive animals fed with
STD (p = 0.0169 ) or HFD (p = 0.0078).
Upregulation of Respiratory Chain Complexes
Occurred Mainly in the Frontal Cortex
After the estimation of the glycolysis process and the Krebs
cycle, the next stage of metabolism, i.e., oxidative phosphor-
ylation was assessed by determining the expression of respi-
ratory chain complexes.
There was no effect of prenatal stress, HFD, or the PS/HFD
interaction on the expression of complexes I and III in the
frontal cortex but a significant effect of PS (F2,36 = 3.71, p =
0.0343) on complex II, an effect of PS (F2,35 = 5.60, p =
0.0078) and HFD (F1,35 = 5.24, p = 0.0282) on complex V
and an effect of the PS/HFD interaction (F2,34 = 3.84, p =
0.0312) on complex IV (Fig. 8A, C, E, G, I) were observed.
Post hoc analysis showed an increase in complex II expression
in PS-NR rats fed with a STD (p = 0.0417) and HFD (p =
0.0265), increase in complex IV in the control/HFD group (p
= 0.0150) and in PS-NR rats fed with a STD (p = 0.0061) and
HFD (p = 0.0277), and elevated expression of complex V in
the control/HFD group (p = 0.0439), PS-R/HFD (p = 0.0328),
Fig. 5 The effect of prenatal
stress and high-fat diet on the ex-
pression of phosphofructokinase
(PFK-1 L) in the frontal cortex
(A) and hippocampus (B) and L-
lactate concentrations in the fron-
tal cortex (C) and hippocampus
(D). The results are expressed as
the means ± SEM. (a*b)
Statistically significant effect of
prenatal stress/HFD interaction.
*p < 0.05 vs. control group
(without prenatal stress, fed with
STD); #p < 0.05 vs. appropriate
STD group. n = 8
Fig. 6 The effect of prenatal stress and high-fat diet on the glucose-6-
phosphate dehydrogenase (G-6-PD) activity in the frontal cortex (A) and
hippocampus (B). The results are expressed as the means ± SEM. (a)
Statistically significant effect of prenatal stress; (a*b) statistically
significant effect of prenatal stress/HFD interaction. *p < 0.05 vs. control
group (without prenatal stress, fed with STD); #p < 0.05 vs. appropriate
STD group; &p < 0.05 vs. control group (without prenatal stress, fed with
HFD). n = 8
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and PS-NR groups fed with a STD (p = 0.0114) and HFD (p =
0.0010). In the second examined brain structure, the hippo-
campus, ANOVA revealed that PS exerted an effect (F2,39 =
4.11, p = 0.0241) only on complex III expression, while no
effect of the HFD or PS/HFD interaction on the level of any
complex was observed (Fig. 8B, D, F, H, J). Post hoc test
showed an increase in complex III expression in PS-R rats
fed with a STD (p = 0.0111).
PS Increased While HFD Lowered the OXPHOS State
Activity
Because PS and HFD influenced expression of respiratory
chain complexes mainly in the frontal cortex, mitochondrial
respiratory function was determined in this brain region.
To characterize mitochondrial function, the oxygen con-
sumption rate (OCR) was determined at selected steps of ox-
idative phosphorylation in isolated mitochondrial fractions of
the frontal cortex.
Using ANOVA, it has been found that PS affected the
routine state (F1,11 = 6.92, p = 0.0234), and the Duncan test
showed a significant increase in both PS-R/STD (p = 0.0135 )
and PS-R/HFD (p = 0.0431 ) groups (Fig. 9A). In the ADP-
stimulated state, the effect of HFDwas observed (F1,11 = 8.67,
p = 0.0186); however, post hoc test did not show significant
differences between any of the groups (Fig. 9B).
Both investigated factors, PS (F1,13 = 15.92, p = 0.0015)
and HFD (F1,13 = 6.23, p = 0.0267), affected the OXPHOS
state (after succinate addition) and uncoupled state (evaluated
in the presence of FCCP) (F1,13 = 24.86 PS, p = 0.0002 and
F1,13 = 9.57 HFD, p = 0.0086) (Fig. 9C, D). A significant
increase in the OXPHOS capacity and uncoupled state in the
PS-R/STD groups in comparison to the control/STD rats (for
OXPHOS, p = 0.0409; for uncoupled state, p = 0.0259), de-
crease in the control/HFD in comparison to the control/STD
(for OXPHOS, p = 0.0458; for uncoupled, p = 0.0090) and
difference between the control/HFD and PS-R/HFD groups
(for OXPHOS, p = 0.0080; for uncoupled, p = 0.0010) were
shown by post hoc analysis.
In the leak state measured in the absence of ADP, ANOVA
revealed only an effect of HFD (F1,14 = 5.72, p = 0.0314), but
post hoc test showed an increase in the PS-R/STD animals in
relation to control/STD group (p = 0.0369) and significant
decrease in PS-R/HFD group vs. PS-R/STD (p = 0.0257)
(Fig. 9E).
PS and HFD Had No Significant Effect on ATP
Synthesis in the Frontal Cortex and Hippocampus
ATP concentration was assayed in order to determine whether
changes in the expression and function of mitochondrial com-
plexes influenced its synthesis.
No significant effect of prenatal stress, the HFD, and their
interaction on the ATP concentration in the frontal cortex or
hippocampus was observed (Table 1).
No Effect of PS and HFD on UCP4 Level in the Frontal
Cortex and Hippocampus
Increased oxygen consumption rate in the leak state in prena-
tally stressed rats suggested uncoupling of oxidative phos-
phorylation from ATP synthesis; therefore, expression of
uncoupling protein (UCP4) was determined.
No significant effect of prenatal stress, the HFD, or their
interaction on the UCP4 level in the frontal cortex or hippo-
campus was detected (Table 2).
PS Increased the Level of Insulin in the Frontal Cortex,
but Decreased Its Concentration in the Hippocampus
Insulin is major hormone regulating glucose metabolism in
the periphery and in the brain in addition to the neuroprotec-
tive effect also can affect metabolism; therefore, insulin, insu-
lin receptor expression, and Akt phosphorylation in the frontal
cortex and hippocampus were studied.
Prenatal stress influenced insulin levels in the frontal cortex
and hippocampus in an inverse way. We showed a significant
effect of PS (F2,51 = 3.78, p = 0.0296) andHFD (F1,51 = 4.40, p =
0.0408) on insulin concentration in the frontal cortex, and further
analysis indicated an increase in this hormone level in all exper-
imental groups in comparison to the control/STD rats (control/
HFD: p = 0.0095; PS-R/STD: p = 0.0131; PS-R/HFD: p =
Fig. 7 The effect of prenatal stress and high-fat diet on the activity of
pyruvate dehydrogenase (PDH) in the frontal cortex (A) and hippocam-
pus (B). The results are expressed as the means ± SEM. (b) Statistically
significant effect of HFD. *p < 0.05 vs. control group (without prenatal
stress, fed with STD). n = 8
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0.0008; PS-NR/STD: p = 0.0034; PS-NR/HFD: p = 0.0104 )
(Fig. 10A). In the hippocampus, PS (F2,42 = 13.86, p < 0.0001)
and the PS/HFD interaction (F2,42 = 4.38, p = 0.0188) affected
insulin levels (Fig. 10B). Moreover, post hoc analysis showed
that in all animals subjected to prenatal stress, both those receiv-
ing the STD and HFD, levels of this hormone were lower than
those in control/STD animals (PS-R/STD: p = 0.0005; PS-R/
HFD: p = 0.0271; PS-NR/STD: p < 0.0001; PS-NR/HFD: p =
0.0047). Moreover, insulin level was significantly lower in PS-
NR/STD group than in PS-NR/HFD (p = 0.0246). The ratio of
phosphorylated to total receptor forms (p-IR/IR) in the frontal
cortex and hippocampus (Fig. 10C, D) did not differ between
the groups. Furthermore, no significant effect of PS, the HFD, or
their interaction on the ratio of phosphorylated to total Akt form
in the frontal cortex or hippocampus was detected (Fig. 10E, F).
PS and HFD Decreased GLP-1 Concentration
in the Frontal Cortex but Not in the Hippocampus
In addition to insulin, GLP-1 is the secondmajor hormone that
regulates peripheral and possibly also brain metabolism, so its
concentration and expression of its receptors in the frontal
cortex and hippocampus were determined.
Fig. 8 The effect of prenatal
stress and high-fat diet on the ex-
pression of complexes I –V in the
frontal cortex (A, C, E, G, I) and
hippocampus (B, D, F, H, J). (K.1/
L.1) Representative immunoblots
of OXPHOS complexes (frontal
cortex, hippocampus, respective-
ly). The bands from the left: (1)
Ctrl/STD; (2) Ctrl/HFD; (3) PS-
R/STD; (4) PS-R/HFD; (5) PS-
NR/STD; (6) PS-NR/HFD. (K2/
L2) β-Actin as a loading control.
The results are expressed as the
means ± SEM. (a) statistically
significant effect of prenatal
stress; (b) statistically significant
effect of HFD; (a*b) statistically
significant effect of prenatal
stress/HFD interaction. *p < 0.05
vs. control group (without prena-
tal stress, fed with STD). n = 6–8
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ANOVA showed an effects of PS (F2,61 = 4.59, p = 0.0139)
and PS/HFD interaction (F2,61 = 3.44, p = 0.0385) in the
frontal cortex. Further analysis revealed a decrease in GLP-1
levels in all experimental groups in comparison to that in the
control/STD animals (control/HFD: p = 0.0052; PS-R/STD: p
= 0.0020; PS-R/HFD: p = 0.0012; PS-NR/STD: p = 0.0023;
PS-NR/HFD: p = 0.0065 (Fig. 11A). However, none of the
factors studied affected the level of GLP-1R and GLP-2R in
the frontal cortex (Fig. 11C, E).
In the hippocampus, none of the factors studied (PS, HFD,
and PS/HFD interaction) had an effect on the level of GLP-1.
ANOVA showed an effect of HFD on GLP-1 receptor (GLP-
1R) level (F1,38 = 10.43, p = 0.0026) and GLP-2 receptor
GLP-2R (F1,39 = 12.09, p = 0.0013) (Fig. 11D, F) in the
hippocampus. We observed a decrease in GLP-1R level in
PS-R/HFD rats in comparison to control/STD (p = 0.0241)
and PS-R/STD groups (p = 0.0133). In contrast to the GLP-
1R receptor, the HFD increased the level of GLP-2R in control
animals, PS-R and PS-NR animals fed with the HFD (control/
HFD: p = 0.0317; PS-R/HFD: p = 0.0140; PS-NR/HFD: p =
0.0152). Moreover, we observed the increase in GLP-2R in
PS-NR/HFD animals in comparison to PS-NR/STD (p =
0.0176) (Fig. 11F).
Table 3 displays the most important effects observed in
selected markers. It contains the results from selected groups
essential for the study described in the article.
Table 1 The effects of prenatal stress and 16 weeks on a high-fat diet on the level of ATP in the frontal cortex and hippocampus
ATP (nmol/g protein) Control PS reactive PS nonreactive
STD HFD STD HFD STD HFD
Frontal cortex 375.6 ± 34.94 367.4 ± 47.43 385.0 ± 36.45 405.4 ± 52.77 444.0 ± 7.92 380.8 ± 26.08
Hippocampus 408.0 ± 50.60 314.2 ± 24.96 347.3 ± 34.28 367.4 ± 37.26 306.9 ± 50.53 261.8 ± 37.85
The results are presented as nmol/g protein and expressed as the means ± the SEM from 8 animals per group
Fig. 9 The effect of prenatal
stress and high-fat diet on the ox-
ygen consumption rate (OCR) in
mitochondria isolated from the
frontal cortex. Routine state (A).
ADP-stimulated respiration (B).
OXPHOS capacity (C).
Uncoupled respiration measured
in the presence of FCCP (D).
Leak respiration measured in the
absence of ADP (E). The results
are expressed as the means ±
SEM. (a) Statistically significant
effect of prenatal stress; (b) sta-
tistically significant effect of
HFD. *p < 0.05 vs. control group
(without prenatal stress, fed with
STD); #p < 0.05 vs. appropriate
STD group; &p < 0.05 vs. control
group (without prenatal stress, fed
with HFD). n = 2–6
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Discussion
The present study has shown that both prenatal stress and the
HFD increased glucose-6-phosphate levels in the hippocam-
pus, whereas in the frontal cortex, this effect was observed in
prenatally stress-nonreactive animals, while in stress-reactive
only in these receiving HFD. Although the metabolic process-
es in the brain are relatively poorly understood, glucose is
recognized as the main source of energy in the brain.
Glucose-6-phosphate is formed from glucose transported to
cells and is a substrate in various metabolic pathways of car-
bohydrate metabolism. Increased concentrations of G-6-P in
the hippocampus of prenatally stressed animals and in the
frontal cortex in PS-R rats fed with HFD suggested that in
the depression or depression with obesity models used,
glucose uptake into brain cells was enhanced or its metabo-
lism was slower. These data are in line with our previous
results, which showed an increased hippocampal glucose level
in prenatally stressed 3-month-old rats (Detka et al. 2014).
Some quantities of G-6-P may be formed in the glycogenoly-
sis process from glycogen stored in astrocytes; however, since
prenatal stress enhanced glycogen content in the hippocampus
of PS-R rats and in the frontal cortex in PS-R animals fed with
HFD, such a possibility could be excluded. Although func-
tional consequences of increased glycogen storage in the brain
structures are difficult to predict, its increased accumulation is
often associated with reduced neuronal activity. Inhibition of
glycogen metabolism has been shown to reduce the formation
of miniature postsynaptic stimulating potentials in co-cultures
of neurons and astrocytes (Mozrzymas et al. 2011) and also
Table 2 The effects of prenatal
stress and 16 weeks on a high-fat
diet on the level of UCP4 in the
frontal cortex and hippocampus
UCP4
(fold change)
Control PS reactive PS nonreactive
STD HFD STD HFD STD HFD
Frontal cortex 1.00 ± 0.09 0.59 ± 0.06 0.85 ± 0.08 1.11 ± 0.20 0.94 ± 0.14 0.90 ± 0.13
Hippocampus 1.00 ± 0.10 0.92 ± 0.16 1.01 ± 0.18 0.97 ± 0.20 1.19 ± 0.15 0.82 ± 0.15
The results are presented as fold of change and expressed as the means ± the SEM from 7–8 animals per group
Fig. 10 The effect of prenatal
stress and high-fat diet on the in-
sulin concentration in the frontal
cortex (A) and hippocampus (B),
on the ratio of active to inactive
forms of the insulin receptor (IR)
in the frontal cortex (C) and hip-
pocampus (D), and on the ratio of
phospho-Akt (Ser473)/Akt in the
frontal cortex (E) and hippocam-
pus (F). The bands from the left:
(1) Ctrl/STD; (2) Ctrl/HFD; (3)
PS-R/STD; (4) PS-R/HFD; (5)
PS-NR/STD; (6) PS-NR/HFD. β-
Actin as a loading control (E, F).
The results are expressed as the
means ± SEM. (a) Statistically
significant effect of prenatal
stress, (b) statistically significant
effect of HFD, (a*b) statistically
significant effect of prenatal
stress/HFD interaction. *p < 0.05
vs. control group (without prena-
tal stress, fed with STD); #p <
0.05 vs. appropriate STD group. n
= 6–10 (A–D), n = 4–6 (E–F)
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contributed to the impairment of processes related to memory
consolidation in the hippocampus of rodents (Newman et al.
2011). The high-fat diet also increased G-6-P levels in the
hippocampus and enhanced the prenatal stress effect on this
glucose metabolite only in prenatal stress-nonresponsive rats
and not in those animals in which stress-induced depression-
like behavior. Increased levels of G-6-P and glycogen in the
frontal cortex of PS-NR rats may to some extent result from
the increased expression of the GLUT1 transporter, which in
the hippocampus and frontal cortex occurs in much higher
Fig. 11 The effect of prenatal
stress and high-fat diet on the ex-
pression of GLP-1 (A), GLP-1
receptor (C), and GLP-2 receptor
(E) in the frontal cortex and on the
expression of GLP-1 (B), GLP-1
receptor (D), and GLP-2 receptor
(F) in the hippocampus. The re-
sults are expressed as the means ±
SEM. (a) Statistically significant
effect of prenatal stress; (b) sta-
tistically significant effect of
HFD; (a*b) statistically signifi-
cant effect of prenatal stress/HFD
interaction. *p < 0.05 vs. control
group (without prenatal stress, fed
with STD); #p < 0.05 vs. appro-
priate STD group. n = 7–14
Table 3 The summary of the most important effects observed in the chosen markers. The changes in selected groups of animals (in comparison to Ctrl/
STD group) are shown
Frontal cortex Hippocampus
Ctrl/STD Ctrl/HFD PS-R/STD PS-R/HFD Ctrl/STD Ctrl/HFD PS-R/STD PS-R/HFD
Glucose-6-phosphate – – ↑ ↑ ↑ ↑
Glycogen – – ↑ – ↑ –
GLUT4-membrane – – ↓ – – –
PDH activity – – – ↓ ↓ ↓
G-6-PD activity – ↑ – – – –
Insulin ↑ ↑ ↑ – ↓ ↓
GLP-1 ↓ ↓ ↓ – – –
GLP-1R – – – – – ↓
GLP-2R – – – ↑ – ↑
Complex III – – – – ↑ –
Complex IV ↑ – – – – –
Complex V ↑ – ↑ – – –
Oxygen consumption rate
Routine respiration – ↑ ↑ Not tested
OXPHOS capacity ↓ ↑ –
Uncoupled ↓ ↑ –
Leak state – ↑ –
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concentration than GLUT3 and GLUT4 (Detka et al. 2014),
and it has been shown that some factors producing adverse
effects on the brain increase its concentration (Gerhart et al.
1994; Carver et al. 1999). However, this relationship was only
seen in PS-NR animals fed a high-fat diet in which an in-
creased GLUT1 level in the frontal cortex was accompanied
by elevated glycogen and G-6-P expression. It is difficult to
explain why the increase in the concentrations of G-6-P and
glycogen or expression ofmitochondrial complex Vwas more
visible in the frontal cortex in stress-nonreactive than stress-
reactive animals. It is known, that not all animals respond to
some stress procedures used in animal models of depression
with behavioral depression-like symptoms, but they predom-
inantly cause similar biochemical changes (Kolasa et al. 2014;
Kurek et al. 2018). Maybe some of these changes are adaptive
and delay the onset of pro-depressive behavior.
Assessing the process of glycolysis, we showed that prena-
tal stress and HFD did not affect either of the key enzymes
involved in this process—phosphofructokinase or the main
brain metabolite, lactate in responsive animals. This is consis-
tent with our previous studies in which we did not observe an
effect of prenatal stress on these markers under the basal con-
ditions; however, acute stress and/or glucose load increased
the expression of these markers in the frontal cortex of prena-
tally stressed animals (Detka et al. 2015), which proves that
prenatal stress intensifies the glycolysis process, but only in
response to additional stressors applied in the adulthood.
The next process of glucose metabolism, i.e., transforma-
tion of pyruvate into acetyl-CoA by the pyruvate dehydroge-
nase complex, seems to be weakened in the hippocampus by
prenatal stress and HFD. Lower activity of this enzyme was
observed in control animals fed a high-fat diet and PS-R rats
fed with both standard and high-fat diet; however, the HFD
did not exacerbate changes in the activity of this enzyme in-
duced by prenatal stress. Interestingly, pyruvate dehydroge-
nase activity in the hippocampus of PS-NR rats did not sig-
nificantly differ from the activity of this enzyme in control
animals. In the depression model used, similar to other animal
models of depression, despite the action of identical stress
factors, behavioral depression-like changes were present in
some (PS-R) but not all animals, and so far, the cause of these
differences has not been explained. Maybe one of the reasons
is a weaker inhibitory effect of stress factors on the activity of
pyruvate dehydrogenase in the hippocampus. The reduced
activity of pyruvate dehydrogenase observed only in the hip-
pocampus and not in the frontal cortex could have resulted
from the differences in insulin concentration in these two brain
structures; prenatal stress decreased the level of insulin in the
hippocampus, while in the frontal cortex, both stress and HFD
increased the concentration of this hormone. Insulin increases
the activity of pyruvate dehydrogenase in peripheral tissues,
and although this action in the brain was not investigated, it
cannot be excluded.
Intensification by prenatal stress of almost all measured
steps of oxidative phosphorylation and enhanced expression
of some mitochondrial complexes in the frontal cortex con-
firmed the increased oxidative phosphorylation in this brain
structure. However, prenatal stress had no effect on ATP syn-
thesis, which suggested reduced mitochondrial respiration ef-
ficiency. Because prenatal stress enhanced the oxygen con-
sumption rate in the leak state when oxygen flux is maintained
mainly to compensate for the proton leak when ATP synthase
is not active, this suggested that in prenatally stressed rats fed
with STD, the inner mitochondrial membrane was more per-
meable to protons and as a consequence, uncoupling of oxi-
dative phosphorylation from ATP synthesis may occur and
thus reduce ATP synthesis by complex V. Increased expres-
sion of some mitochondrial complexes and activity of the
OXPHOS state induced by prenatal stress could be a compen-
satory mechanism activated in response to the decrease in
mitochondrial ATP production. Then we checked whether
the process of uncoupling oxidative phosphorylation from
ATP synthesis may depend on overexpression of uncoupling
protein 4 (UCP4). We did not observe an increase in UCP4
levels in the frontal cortex, which indicated that this protein
was not involved in prenatal stress-induced metabolic chang-
es. However, the process of oxidative phosphorylation
uncoupling in the brain can also be regulated by other factors
such as UCP5, insulin-like growth factor, and mitochondrial
fusion proteins (Liu et al. 2006; Logan et al. 2018).
Because the level of ATP in the frontal cortex was not
reduced by prenatal stress, it seemed, therefore, that the in-
crease in oxidative phosphorylation was sufficient to maintain
the production of ATP in basal condition. However, under
stress conditions, it is possible that there is a shift of the
amount of ATP synthesized in the frontal cortex from oxida-
tive phosphorylation to glycolytic processes, because previ-
ously we found that prenatal stress increased the expression of
the key enzyme of glycolysis—phosphofructokinase—and
the main product of glycolysis—lactate—in the frontal cortex
of rats subjected to stress in adulthood (Detka et al. 2015).
Such a shift in the mode of ATP production was previously
observed in pheochromocytoma (PC12) cell lines (Liu et al.
2006). The HFD increased the expression of complexes IV
and V in the frontal cortex in control rats; however, it inhibited
OXPHOS and uncoupled states in control animals. It seems,
therefore, that HFD affected the permeability of the mitochon-
drial membrane in a way opposite to that of prenatal stress;
however, this effect did not translate into an increase in ATP
synthesis.
In this study, we did not evaluate the activity of particular
steps of oxidative phosphorylation in the hippocampus, so it is
impossible to tell whether similar changes may also occur in
this brain structure. However, our study showed that prenatal
stress also raised the expression of complex III in this
structure.
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Many data have shown that the HFD differentially affects
the effects of stress (Finger et al. 2011). In the present study,
the HFD intensified the effects of prenatal stress only on
glucose-6-phosphate concentration in the hippocampus in
PS-NR rats, on GLUT1 expression in the frontal cortex in
PS-NR rats and on the decrease in the membrane GLUT4 in
the frontal cortex in PS-R animals. In contrast, the HFD weak-
ened some of the prenatal stress-induced effects, such as the
decrease in lactate and insulin levels in the hippocampus of
PS-NR rats and the increase in the oxygen consumption rate in
the OXPHOS, uncoupled and leak states of oxidative phos-
phorylation in the frontal cortex. It should be noted that al-
though in the present investigation, effectiveness of the HFD
was checked only by demonstrating its effect on the weight
gain, whereas in our previous study, conducted in animals
treated in the same way, we found that HFD significantly
increased blood insulin levels (Kurek et al. 2018).
Because insulin and GLP-1 are fundamentally involved in
the regulation of glucose metabolism in the periphery and it is
known that these hormones also affect brain metabolism
(Detka et al. 2013; Bassil et al. 2014), their concentrations
were measured. In the frontal cortex, both prenatal stress and
the HFD increased insulin levels; however, a decrease in the
membrane glucose transporter (GLUT4) observed in the PS-
R/HFD rats suggested weaker insulin action in the model of
coexistence of depression and obesity. The same data showed
that glucocorticoids caused insulin resistance not only in the
periphery but also in the brain, but so far it has been demon-
strated mainly in the hypothalamus (Pan et al. 2013).
Diminished level of membrane GLUT4 in the frontal cortex
of PS-R/HFD group and higher insulin concentration than in
the control animals suggested that in animals in which prena-
tal stress caused depression-like symptoms and which addi-
tionally received a high-fat diet in adulthood, insulin resis-
tance in the frontal cortex may develop. However, this sug-
gestion can only be confirmed by demonstrating such a
change in animals after insulin administration. Moreover, de-
creased membrane GLUT4 level was not associated with the
reduction of p-IR and p-Akt levels—PS and HFD did not
change concentrations of p-IR/IR and p-Akt/Akt ratio. It is
possible that weaker insulin effect in the frontal cortex in
PS-R/HFD rats resulted from the disturbance in a further stage
of intracellular insulin pathway.
Both prenatal stress and the HFD decreased the
frontocortical levels of GLP-1, a hormone which in addition
to the effect on metabolism in the periphery and brain exerts a
number of neuroprotective effects, and this may be the reason
why our previous studies indicate that prenatal stress causes
more adverse changes in the frontal cortex than in the hippo-
campus (Kucharczyk et al. 2018) in contrast to the majority of
data indicating that the hippocampus is the brain structure
most sensitive to damage. In the hippocampus, the level of
GLP-1 did not change under the influence of prenatal stress
and the HFD, but in this structure, the HFD caused a decrease
in expression of its receptors, however, at the same time, there
was a compensatory increase in the expression of the receptor
for GLP-2, which, like GLP-1, exerts an anorectic and neuro-
protective effect.
Some of the changes observed in the present study in ani-
mals fed a HFD are similar to those reported in obese people.
For example, our research has shown that HFD decreased
some state of oxidative phosphorylation in the frontal cortex
and similar changes were found in skeletal muscle of type 2
diabetic patients (Mogensen et al. 2007). Moreover, in the
current studies, HFD decreased the level of GLP-1 in the
frontal cortex and in obese people, and plasma level of this
hormone was also lower than in controls (Hussein et al. 2014).
Similar effect on GLUT1 transporters to that which we ob-
served in the frontal cortex of PS-NR rats fed a HFD was
detected in fibroblast and skeletal muscles of obese people
(Miele et al. 1997).
Some PS- or HFD-induced changes were dependent on the
brain structure studied. A decrease in pyruvate dehydrogenase
activity, indicating a weakening of the Krebs cycle, was ob-
served only in the hippocampus, while a decrease in the
GLUT4 transporter in the membrane fraction was seen only
in the frontal cortex. Among markers related to
neurodegeneration/neuroprotection processes, the changes oc-
curred mainly in the frontal cortex, but it is difficult to predict
their consequences, because prenatal stress increased G6PD
activity in PS-R/STD animals, suggesting protective effect,
but on the other hand both PS and HFD strongly reduced the
level of the neuroprotective peptide—GLP-1. However, it ap-
pears that the changes observed in the frontal cortex did not
lead to disturbance in short-term memory processes, because
previously we found no effect of prenatal stress and HFD on
cortex-dependent short-term memory determined in the novel
object recognition test (Kurek et al. 2018).
In conclusion, the obtained results indicated that not all
effects observed after prenatal stress and high-fat diet could
be considered as adverse changes; they depended on the brain
structure studied and some PS- and HFD-induced effects were
opposite. Most of the observed changes appear to be unfavor-
able; however, PS-induced increase in G6PD activity in the
frontal cortex maybe propitious because this enzyme is essen-
tial for the generation of NADPH and protection against oxi-
dative stress-induced cellular damage. Also HFD-induced in-
crease in GLP-2 receptor level in hippocampus, which may
increase neuroprotective GLP-1 action, seems to be beneficial.
Among the changes that may be relevant in the case of coex-
istence of depression and obesity, the increase in the level of
G-6-P, glycogen, and reduction of the membrane GLUT4 in
the frontal cortex seem to be particularly important, because
these changes were present only in PS-R/HFD group, but not
in control/HFD or PS-R/STD. Among these changes, the de-
creased GLUT4 expression in the membrane fraction of the
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frontal cortex suggested weaker insulin action only in the case
of co-occurrence of depression and obesity. On the other hand,
since obesity and prenatal stress induced opposite changes in
the oxygen consumption rate in the frontal cortex, these
changes were less pronounced in comorbidity of depression
and obesity. In the hippocampus, in the model of the co-
occurrence of depression and obesity, the decreased in GLP-
1 receptor suggests that neurodegenerative changes may be
more severe in the case of coexistence of the two diseases
compared to those observed in obesity or in depression.
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